Leng et al. 52 week results tocilizumab biosimilar vs originator in RA. Shocker, it's the same. @RheumNow #ACR22 Abstr#0917 https://t.co/5JAoGBRzUi https://t.co/7zCUNcdzbp
Links:
Fifty-two-week Results from a Phase 3, Randomized, Double-blind, Active-control…
https://acrabstracts.org/abstract/fifty-two-week-results-from-a-phase-3-randomi…
13-11-2022
